Iterative Health

Iterative Health operates a specialized clinical research network that brings trials in gastroenterology, hepatology, obesity, and cardiology into community healthcare settings. The company helps medical providers and study sponsors accelerate site activation, improve patient enrollment, and conduct research more efficiently with operational expertise and AI-enabled tools.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
Share Price
Series C30 Apr, 2026
***
***
***
Series B19 Jan, 2022
***
***
***
Series A3 Aug, 2021
***
***
***
Series A1 Sep, 2020
***
***
***
Series A14 Oct, 2019
***
***
***
Seed15 Jun, 2019
***
***
***

*** - To view the data, please log into your account or create a new one.

Company valuation calculator

To calculate, specify one of the parameters

News related to Iterative Health1

Filter by
Sort by
Iterative Health
Apr 30, 2026 •Show on chart

Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinical Research

Clinical trials are critical in bridging scientific discovery and patient care; however, systematic challenges delay the delivery ...

https://www.businesswire.com/news/home/20260430725010/en/Iterative-Health-Closes-%2477-Million-Series-C-to-Accelerate-the-Future-of-Clinical-Research